开启国内临床应用！美敦力可充电、可感知闭环脑起搏器

Core Insights - The Percept™ RC, the world's first rechargeable and sensing closed-loop brain stimulator, has commenced clinical applications in major hospitals across Beijing, Anhui, and Shanxi as of November 2025 [1][4] - Developed by Medtronic, the device integrates artificial intelligence and brain-machine interface technology, and is approved by the Chinese National Medical Products Administration, the US FDA, and the EU CE for treating complex neurological disorders such as Parkinson's disease and drug-resistant epilepsy [3][4] - The device has been recognized as one of TIME magazine's "Best Inventions of 2025" and has been featured prominently at the China International Import Expo [3][4] Clinical Application - The clinical application of Percept™ RC marks a significant breakthrough in brain stimulator therapy, advancing the use of brain-machine interface technology for treating neurological diseases in China [4] - The device offers a more intelligent, precise, and comfortable treatment option for patients, enhancing the overall treatment experience [4][8] Technological Advancements - Compared to traditional brain stimulators, Percept™ RC provides real-time sensing and analysis of brain activity, allowing for personalized and precise treatment tailored to the patient's condition [8] - It is the smallest and lightest brain stimulator globally, being 37% smaller than traditional models, which improves patient comfort [8] - The device features an open lifespan battery technology and is fully compatible with 3.0T and 1.5T MRI scans, ensuring patient safety and access to future medical imaging [8] Historical Context - Deep brain stimulation (DBS), commonly known as "brain pacemaker," has been recognized as the preferred surgical treatment for Parkinson's disease since its first successful operation in 1987 [5] - The therapy has been clinically applied for over 35 years globally, with its introduction to China occurring in 1999 [5]